chr5-1394998-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001044.5(SLC6A3):​c.1840-240G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 152,316 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.014 ( 26 hom., cov: 33)

Consequence

SLC6A3
NM_001044.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -4.84

Publications

1 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 5-1394998-C-T is Benign according to our data. Variant chr5-1394998-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1212204.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.014 (2133/152316) while in subpopulation NFE AF = 0.0216 (1466/68016). AF 95% confidence interval is 0.0206. There are 26 homozygotes in GnomAd4. There are 951 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.1840-240G>A intron_variant Intron 14 of 14 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.1840-240G>A intron_variant Intron 14 of 14 1 NM_001044.5 ENSP00000270349.9 Q01959
SLC6A3ENST00000512002.2 linkn.221-240G>A intron_variant Intron 2 of 2 1
SLC6A3ENST00000713696.1 linkc.*35-240G>A intron_variant Intron 14 of 14 ENSP00000519000.1

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2132
AN:
152198
Hom.:
26
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00468
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0151
Gnomad ASJ
AF:
0.0193
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.00574
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0216
Gnomad OTH
AF:
0.0277
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0140
AC:
2133
AN:
152316
Hom.:
26
Cov.:
33
AF XY:
0.0128
AC XY:
951
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00469
AC:
195
AN:
41578
American (AMR)
AF:
0.0152
AC:
232
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
67
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4826
European-Finnish (FIN)
AF:
0.00574
AC:
61
AN:
10622
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0216
AC:
1466
AN:
68016
Other (OTH)
AF:
0.0274
AC:
58
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
110
220
329
439
549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
22
Bravo
AF:
0.0155
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Oct 02, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.016
DANN
Benign
0.61
PhyloP100
-4.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28363164; hg19: chr5-1395113; API